Three new partners
The TWB consortium has welcomed 3 new partners on January 2020 : Elaia, Néomerys and Sensient.
![](https://www.toulouse-white-biotechnology.com/wordpress/wp-content/uploads/2020/03/Logo-NEW-Sensient-Cosmetics-Technologies_vectorisé-ARGENT-300x66.png)
![](https://www.toulouse-white-biotechnology.com/wordpress/wp-content/uploads/2020/03/Logo-Néomerys-V8-1-300x97.jpg)
![](https://www.toulouse-white-biotechnology.com/wordpress/wp-content/uploads/2020/03/Logo_Elaia_RubriquePartenaires.jpg)
Elaia is a venture capital fund investing in particular in high-potential digital and deeptech start-ups (including Life Sciences). In this context, Elaia works a lot with the research world.
The consortium is now composed of 52 private and public partners (8 large companies, 2 mid-cap company, 7 small and medium companies, 19 very small companies, 5 investors, 3 valorisation structures, 9 public partners). The companies operate in different fields: Agro-industry / Chemicals (materials and products) / Equipment / Biotechnology solutions / Flavors and Cosmetics / Energy and Pharmacy.